Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance

Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function, inflammation, free radical production, vascular dysfunction, and subsequently a greater incidence of cardiovascular disease. By administering an acute oral antioxidant cocktail to patients with COPD (n=30) and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2014-03, Vol.63 (3), p.459-467
Hauptverfasser: Ives, Stephen J., Harris, Ryan A., Witman, Melissa A.H., Fjeldstad, Anette S., Garten, Ryan S., McDaniel, John, Wray, D. Walter, Richardson, Russell S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 467
container_issue 3
container_start_page 459
container_title Hypertension (Dallas, Tex. 1979)
container_volume 63
creator Ives, Stephen J.
Harris, Ryan A.
Witman, Melissa A.H.
Fjeldstad, Anette S.
Garten, Ryan S.
McDaniel, John
Wray, D. Walter
Richardson, Russell S.
description Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function, inflammation, free radical production, vascular dysfunction, and subsequently a greater incidence of cardiovascular disease. By administering an acute oral antioxidant cocktail to patients with COPD (n=30) and controls (n=30), we sought to determine the role of redox balance in the vascular dysfunction of these patients. Using a double-blind, randomized, placebo-controlled, crossover design, patients with COPD and controls were ingested placebo or the antioxidant cocktail (vitamin C, vitamin E, α-lipoic acid) after which brachial artery flow-mediated dilation and carotid-radial pulse wave velocity were assessed using ultrasound Doppler. The patients exhibited lower baseline antioxidant levels (vitamin C and superoxide dismutase activity) and higher levels of oxidative stress (thiobarbituic acid reactive species) in comparison with controls. The patients also displayed lower basal flow-mediated dilation (P
doi_str_mv 10.1161/HYPERTENSIONAHA.113.02255
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4476392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24324045</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3305-70ba6184d8cc609d5f3d2edeb54a3e6be45696155950bde2b976905fcd496e2d3</originalsourceid><addsrcrecordid>eNqNkEtvEzEUhS0EoqHlLyCzYDnFz5kYCaSQpqRS1VQhILqyPPYdZsAZV_ZMH_8eQ0qBrlhZOj7n3Hs_hF5SckhpSV8vL84X683i7OPJ6my2nGWRHxLGpHyEJlQyUQhZ8sdoQqgShaL0yx56ltI3QqgQonqK9pjgTBAhJ-jis0l29Cbio9vUjL0dutBj0zs8b2PoO4tXdRrimPUrwOej34bexFt81CUwCd7gTQt4HTzg0OA1uHCD3xtvegsH6EljfILnd-8--nS82MyXxenqw8l8dlpYzoksKlKbkk6Fm1pbEuVkwx0DB7UUhkNZQ75FlVRKJUntgNWqKhWRjXVClcAc30fvdr2XY70FZ6EfovH6MnbbvKgOptP__vRdq7-GK51RlFyxXKB2BTaGlCI091lK9E_e-gHvLHL9i3fOvvh7-H3yN-BseHVnyJyNb2JG06U_vimTqqqq7Hu7810HP0BM3_14DVG3YPzQ_sciPwBba6Bz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Ives, Stephen J. ; Harris, Ryan A. ; Witman, Melissa A.H. ; Fjeldstad, Anette S. ; Garten, Ryan S. ; McDaniel, John ; Wray, D. Walter ; Richardson, Russell S.</creator><creatorcontrib>Ives, Stephen J. ; Harris, Ryan A. ; Witman, Melissa A.H. ; Fjeldstad, Anette S. ; Garten, Ryan S. ; McDaniel, John ; Wray, D. Walter ; Richardson, Russell S.</creatorcontrib><description>Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function, inflammation, free radical production, vascular dysfunction, and subsequently a greater incidence of cardiovascular disease. By administering an acute oral antioxidant cocktail to patients with COPD (n=30) and controls (n=30), we sought to determine the role of redox balance in the vascular dysfunction of these patients. Using a double-blind, randomized, placebo-controlled, crossover design, patients with COPD and controls were ingested placebo or the antioxidant cocktail (vitamin C, vitamin E, α-lipoic acid) after which brachial artery flow-mediated dilation and carotid-radial pulse wave velocity were assessed using ultrasound Doppler. The patients exhibited lower baseline antioxidant levels (vitamin C and superoxide dismutase activity) and higher levels of oxidative stress (thiobarbituic acid reactive species) in comparison with controls. The patients also displayed lower basal flow-mediated dilation (P&lt;0.05), which was significantly improved with antioxidant cocktail (3.1±0.5 versus 4.7±0.6%; P&lt;0.05; placebo versus antioxidant cocktail), but not controls (6.7±0.6 versus 6.9±0.7%; P&gt;0.05; placebo versus antioxidant cocktail). The antioxidant cocktail also improved pulse wave velocity in patients with COPD (14±1 versus 11±1 m·s; P&lt;0.05; placebo versus antioxidant cocktail) while not affecting controls (11±2 versus 10±1 m·s; P&gt;0.05; placebo versus antioxidant). Patients with COPD exhibit vascular dysfunction, likely mediated by an altered redox balance, which can be acutely mitigated by an oral antioxidant. Therefore, free radically mediated vascular dysfunction may be an important mechanism contributing to this population’s greater risk and incidence of cardiovascular disease.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.113.02255</identifier><identifier>PMID: 24324045</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Aged ; Antioxidants - pharmacokinetics ; Antioxidants - therapeutic use ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Brachial Artery - diagnostic imaging ; Brachial Artery - physiopathology ; Cardiology. Vascular system ; Chronic obstructive pulmonary disease, asthma ; Cross-Over Studies ; Disease Progression ; Double-Blind Method ; Endothelium, Vascular - physiopathology ; Female ; Follow-Up Studies ; Humans ; Hypertension - etiology ; Hypertension - metabolism ; Hypertension - physiopathology ; Male ; Medical sciences ; Oxidation-Reduction ; Pneumology ; Prognosis ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - metabolism ; Ultrasonography, Doppler ; Vascular Resistance - physiology ; Vasodilation - physiology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2014-03, Vol.63 (3), p.459-467</ispartof><rights>2014 American Heart Association, Inc</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3305-70ba6184d8cc609d5f3d2edeb54a3e6be45696155950bde2b976905fcd496e2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28259777$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24324045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ives, Stephen J.</creatorcontrib><creatorcontrib>Harris, Ryan A.</creatorcontrib><creatorcontrib>Witman, Melissa A.H.</creatorcontrib><creatorcontrib>Fjeldstad, Anette S.</creatorcontrib><creatorcontrib>Garten, Ryan S.</creatorcontrib><creatorcontrib>McDaniel, John</creatorcontrib><creatorcontrib>Wray, D. Walter</creatorcontrib><creatorcontrib>Richardson, Russell S.</creatorcontrib><title>Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function, inflammation, free radical production, vascular dysfunction, and subsequently a greater incidence of cardiovascular disease. By administering an acute oral antioxidant cocktail to patients with COPD (n=30) and controls (n=30), we sought to determine the role of redox balance in the vascular dysfunction of these patients. Using a double-blind, randomized, placebo-controlled, crossover design, patients with COPD and controls were ingested placebo or the antioxidant cocktail (vitamin C, vitamin E, α-lipoic acid) after which brachial artery flow-mediated dilation and carotid-radial pulse wave velocity were assessed using ultrasound Doppler. The patients exhibited lower baseline antioxidant levels (vitamin C and superoxide dismutase activity) and higher levels of oxidative stress (thiobarbituic acid reactive species) in comparison with controls. The patients also displayed lower basal flow-mediated dilation (P&lt;0.05), which was significantly improved with antioxidant cocktail (3.1±0.5 versus 4.7±0.6%; P&lt;0.05; placebo versus antioxidant cocktail), but not controls (6.7±0.6 versus 6.9±0.7%; P&gt;0.05; placebo versus antioxidant cocktail). The antioxidant cocktail also improved pulse wave velocity in patients with COPD (14±1 versus 11±1 m·s; P&lt;0.05; placebo versus antioxidant cocktail) while not affecting controls (11±2 versus 10±1 m·s; P&gt;0.05; placebo versus antioxidant). Patients with COPD exhibit vascular dysfunction, likely mediated by an altered redox balance, which can be acutely mitigated by an oral antioxidant. Therefore, free radically mediated vascular dysfunction may be an important mechanism contributing to this population’s greater risk and incidence of cardiovascular disease.</description><subject>Aged</subject><subject>Antioxidants - pharmacokinetics</subject><subject>Antioxidants - therapeutic use</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Brachial Artery - diagnostic imaging</subject><subject>Brachial Artery - physiopathology</subject><subject>Cardiology. Vascular system</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Cross-Over Studies</subject><subject>Disease Progression</subject><subject>Double-Blind Method</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension - etiology</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oxidation-Reduction</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - metabolism</subject><subject>Ultrasonography, Doppler</subject><subject>Vascular Resistance - physiology</subject><subject>Vasodilation - physiology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtvEzEUhS0EoqHlLyCzYDnFz5kYCaSQpqRS1VQhILqyPPYdZsAZV_ZMH_8eQ0qBrlhZOj7n3Hs_hF5SckhpSV8vL84X683i7OPJ6my2nGWRHxLGpHyEJlQyUQhZ8sdoQqgShaL0yx56ltI3QqgQonqK9pjgTBAhJ-jis0l29Cbio9vUjL0dutBj0zs8b2PoO4tXdRrimPUrwOej34bexFt81CUwCd7gTQt4HTzg0OA1uHCD3xtvegsH6EljfILnd-8--nS82MyXxenqw8l8dlpYzoksKlKbkk6Fm1pbEuVkwx0DB7UUhkNZQ75FlVRKJUntgNWqKhWRjXVClcAc30fvdr2XY70FZ6EfovH6MnbbvKgOptP__vRdq7-GK51RlFyxXKB2BTaGlCI091lK9E_e-gHvLHL9i3fOvvh7-H3yN-BseHVnyJyNb2JG06U_vimTqqqq7Hu7810HP0BM3_14DVG3YPzQ_sciPwBba6Bz</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Ives, Stephen J.</creator><creator>Harris, Ryan A.</creator><creator>Witman, Melissa A.H.</creator><creator>Fjeldstad, Anette S.</creator><creator>Garten, Ryan S.</creator><creator>McDaniel, John</creator><creator>Wray, D. Walter</creator><creator>Richardson, Russell S.</creator><general>American Heart Association, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201403</creationdate><title>Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance</title><author>Ives, Stephen J. ; Harris, Ryan A. ; Witman, Melissa A.H. ; Fjeldstad, Anette S. ; Garten, Ryan S. ; McDaniel, John ; Wray, D. Walter ; Richardson, Russell S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3305-70ba6184d8cc609d5f3d2edeb54a3e6be45696155950bde2b976905fcd496e2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Antioxidants - pharmacokinetics</topic><topic>Antioxidants - therapeutic use</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Brachial Artery - diagnostic imaging</topic><topic>Brachial Artery - physiopathology</topic><topic>Cardiology. Vascular system</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Cross-Over Studies</topic><topic>Disease Progression</topic><topic>Double-Blind Method</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension - etiology</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oxidation-Reduction</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - metabolism</topic><topic>Ultrasonography, Doppler</topic><topic>Vascular Resistance - physiology</topic><topic>Vasodilation - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ives, Stephen J.</creatorcontrib><creatorcontrib>Harris, Ryan A.</creatorcontrib><creatorcontrib>Witman, Melissa A.H.</creatorcontrib><creatorcontrib>Fjeldstad, Anette S.</creatorcontrib><creatorcontrib>Garten, Ryan S.</creatorcontrib><creatorcontrib>McDaniel, John</creatorcontrib><creatorcontrib>Wray, D. Walter</creatorcontrib><creatorcontrib>Richardson, Russell S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ives, Stephen J.</au><au>Harris, Ryan A.</au><au>Witman, Melissa A.H.</au><au>Fjeldstad, Anette S.</au><au>Garten, Ryan S.</au><au>McDaniel, John</au><au>Wray, D. Walter</au><au>Richardson, Russell S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2014-03</date><risdate>2014</risdate><volume>63</volume><issue>3</issue><spage>459</spage><epage>467</epage><pages>459-467</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function, inflammation, free radical production, vascular dysfunction, and subsequently a greater incidence of cardiovascular disease. By administering an acute oral antioxidant cocktail to patients with COPD (n=30) and controls (n=30), we sought to determine the role of redox balance in the vascular dysfunction of these patients. Using a double-blind, randomized, placebo-controlled, crossover design, patients with COPD and controls were ingested placebo or the antioxidant cocktail (vitamin C, vitamin E, α-lipoic acid) after which brachial artery flow-mediated dilation and carotid-radial pulse wave velocity were assessed using ultrasound Doppler. The patients exhibited lower baseline antioxidant levels (vitamin C and superoxide dismutase activity) and higher levels of oxidative stress (thiobarbituic acid reactive species) in comparison with controls. The patients also displayed lower basal flow-mediated dilation (P&lt;0.05), which was significantly improved with antioxidant cocktail (3.1±0.5 versus 4.7±0.6%; P&lt;0.05; placebo versus antioxidant cocktail), but not controls (6.7±0.6 versus 6.9±0.7%; P&gt;0.05; placebo versus antioxidant cocktail). The antioxidant cocktail also improved pulse wave velocity in patients with COPD (14±1 versus 11±1 m·s; P&lt;0.05; placebo versus antioxidant cocktail) while not affecting controls (11±2 versus 10±1 m·s; P&gt;0.05; placebo versus antioxidant). Patients with COPD exhibit vascular dysfunction, likely mediated by an altered redox balance, which can be acutely mitigated by an oral antioxidant. Therefore, free radically mediated vascular dysfunction may be an important mechanism contributing to this population’s greater risk and incidence of cardiovascular disease.</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>24324045</pmid><doi>10.1161/HYPERTENSIONAHA.113.02255</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2014-03, Vol.63 (3), p.459-467
issn 0194-911X
1524-4563
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4476392
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Aged
Antioxidants - pharmacokinetics
Antioxidants - therapeutic use
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Brachial Artery - diagnostic imaging
Brachial Artery - physiopathology
Cardiology. Vascular system
Chronic obstructive pulmonary disease, asthma
Cross-Over Studies
Disease Progression
Double-Blind Method
Endothelium, Vascular - physiopathology
Female
Follow-Up Studies
Humans
Hypertension - etiology
Hypertension - metabolism
Hypertension - physiopathology
Male
Medical sciences
Oxidation-Reduction
Pneumology
Prognosis
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - drug therapy
Pulmonary Disease, Chronic Obstructive - metabolism
Ultrasonography, Doppler
Vascular Resistance - physiology
Vasodilation - physiology
title Vascular Dysfunction and Chronic Obstructive Pulmonary Disease: The Role of Redox Balance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A50%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20Dysfunction%20and%20Chronic%20Obstructive%20Pulmonary%20Disease:%20The%20Role%20of%20Redox%20Balance&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Ives,%20Stephen%20J.&rft.date=2014-03&rft.volume=63&rft.issue=3&rft.spage=459&rft.epage=467&rft.pages=459-467&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/HYPERTENSIONAHA.113.02255&rft_dat=%3Cpubmed_cross%3E24324045%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24324045&rfr_iscdi=true